Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Nishio

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Clinical Calcium|April 2, 2008
[Efficacy of gefitinib in treatment of lung cancer patients with bone metastasis]Yoshio Okano, Makoto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2018
[Result of Clinical Trials of Ceritinib in Patients with ALK-Rearranged Non-Small-Cell Lung Cancer and Management of the Adverse Events]Miyako Satouchi, Makoto Nishio, Toyoaki Hida, et al.
Targeted Oncology|September 10, 2022
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET InhibitorsMakoto Nishio, Terufumi Kato, Ryo Toyozawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Response to Letter to the EditorMakoto Nishio, Diana Mendus, Lijia Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Identification of Mutation Accumulation as Resistance Mechanism Emerging in First-Line Osimertinib TreatmentKen Uchibori, Naohiko Inase, Makoto Nishio, et al.
JTO Clinical and Research Reports|April 11, 2022
Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary AdenocarcinomaHironori Ninomiya, Kentaro Inamura, Mingyon Mun, et al.
Scientific Reports|June 24, 2017
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregationKenichi Miyata, Ai Takemoto, Sakae Okumura, et al.
Advances in Therapy|August 12, 2023
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based ChemotherapyHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|May 20, 2011
[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib]Noriko Yanagitani, Atsushi Horiike, Keita Kudo, et al.
Leprosy Review|August 10, 2006
Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosyArihiko Kanaji, Masaaki Higashi, Masako Namisato, et al.
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Clinical Calcium|April 2, 2008
[Efficacy of gefitinib in treatment of lung cancer patients with bone metastasis]Yoshio Okano, Makoto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2018
[Result of Clinical Trials of Ceritinib in Patients with ALK-Rearranged Non-Small-Cell Lung Cancer and Management of the Adverse Events]Miyako Satouchi, Makoto Nishio, Toyoaki Hida, et al.
Targeted Oncology|September 10, 2022
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET InhibitorsMakoto Nishio, Terufumi Kato, Ryo Toyozawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Response to Letter to the EditorMakoto Nishio, Diana Mendus, Lijia Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Identification of Mutation Accumulation as Resistance Mechanism Emerging in First-Line Osimertinib TreatmentKen Uchibori, Naohiko Inase, Makoto Nishio, et al.
JTO Clinical and Research Reports|April 11, 2022
Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary AdenocarcinomaHironori Ninomiya, Kentaro Inamura, Mingyon Mun, et al.
Scientific Reports|June 24, 2017
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregationKenichi Miyata, Ai Takemoto, Sakae Okumura, et al.
Advances in Therapy|August 12, 2023
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based ChemotherapyHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|May 20, 2011
[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib]Noriko Yanagitani, Atsushi Horiike, Keita Kudo, et al.
Leprosy Review|August 10, 2006
Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosyArihiko Kanaji, Masaaki Higashi, Masako Namisato, et al.
Pageof 30